{
    "2018-04-16": [
        [
            {
                "time": "2018-04-09",
                "original_text": "How Did Biogen Miss AveXis?",
                "features": {
                    "keywords": [
                        "Biogen",
                        "AveXis",
                        "miss"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "Did Novartis Overpay for AveXis?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "AveXis",
                        "overpay"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "What Novartis Bought in AveXis",
                "features": {
                    "keywords": [
                        "Novartis",
                        "AveXis",
                        "bought"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "Gilead (GILD) Presents Encouraging Data on NASH Therapies",
                "features": {
                    "keywords": [
                        "Gilead",
                        "NASH",
                        "therapies",
                        "encouraging"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "VXUS, NSRGY, NVS, BTI: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "ETF",
                        "inflow",
                        "VXUS",
                        "NSRGY",
                        "NVS",
                        "BTI"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "ETFs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "The Zacks Analyst Blog Highlights: Agios Pharmaceuticals, BioMarin Pharmaceutical, Vertex Pharmaceuticals and Incyte",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Agios",
                        "BioMarin",
                        "Vertex",
                        "Incyte"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "The Swiss Stock Market Dropped As Nestlé Goes Ex-Dividend",
                "features": {
                    "keywords": [
                        "Swiss",
                        "stock market",
                        "Nestlé",
                        "ex-dividend",
                        "dropped"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "NVS: Entresto Preserves Kidney Function In Diabetic Patients With Chronic HF",
                "features": {
                    "keywords": [
                        "NVS",
                        "Entresto",
                        "kidney function",
                        "diabetic",
                        "chronic HF"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}